Loader

Pathways

PathWhiz ID Pathway Meta Data

PW145009

Pw145009 View Pathway
drug action

Quinidine Drug Metabolism Action Pathway

Homo sapiens

PW126647

Pw126647 View Pathway
drug action

Quinine Action Pathway

Homo sapiens
Quinine is an alkaloid used to treat uncomplicated Plasmodium falciparum malaria. It is used parenterally to treat life-threatening infections caused by chloroquine-resistant Plasmodium falciparum malaria. The plasmodium falciparum invades the erythrocytes in blood. Quinine accumulates in the parasite’s food vacuole and inhibits the enzyme heme ligase. Heme ligase is involved in hemoglobin breakdown. Hemoglobin from the erythrocyte is broken down in the digestive vacuole of the parasite. Hemoglobin is first broken down into heme and globin. Globin is further broken down to amino acids which are used by the parasite for nutrition and protein synthesis. Therefore, hemoglobin breakdown is essential for the parasite survival. The heme from hemoglobin is toxic to the parasite and is further broken down by heme ligase to detoxify heme. By quinine inhibiting heme ligase, there is a build up of heme in the parasite vacuole which becomes toxic to the parasite, thereby killing it. Quinine has a bitter taste, and oral compliance is often poor. It is irritant to the gastric mucosa and can cause nausea and vomiting. Cinchonism can occur with exceeded plasma concentration in which symptoms like nausea, dizziness, tinnitus, headache and blurring of vision are experienced. Excessive plasma levels may also cause hypotension, cardiac dysrhythmias and severe central nervous system (CNS) disturbances such as delirium and coma.

PW144590

Pw144590 View Pathway
drug action

Quinine Drug Metabolism Action Pathway

Homo sapiens

PW146618

Pw146618 View Pathway
drug action

Quinupramine Drug Metabolism Action Pathway

Homo sapiens

PW128367

Pw128367 View Pathway
drug action

Quinupristin Action Pathway

Homo sapiens
Quinupristin is an antibiotic agent usually used in combination with dalfopristin, to treat Enterococcus faecium bacteremia and skin infections. It inhibits the late phase of protein synthesis by binding to the 50S ribosomal subunit preventing elongation of the forming polypeptide and causing the protein chain to be released prematurely creating a non-functional protein.

PW145400

Pw145400 View Pathway
drug action

Quinupristin Drug Metabolism Action Pathway

Homo sapiens

PW000836

Pw000836 View Pathway
signaling

Quorum Sensing

Escherichia coli
Bacterial Autoinducer 2 (AI-2) mediates the quorum sensing 2 system. AI-2 is catalyzed by the luxS enzyme found in both E.coli and S.typhimurium. In E. coli and most pathogenic bacteria that form AI-2 are spontaneous transformations that include cyclization to (2R,4S)-2-methyl-2,4-dihydroxydihydrofuran-3-one and hydration to the final autoinducer (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran. This product is then released from the cell through the AI-2 transporter (tqsA). As the level of AI-2 increases, other cells detect it and import it through the autoinducer-2 ABC transporter (lsrACDB). AI-2 is then degraded in the cells by phosphorylating the AI-2 which is then isomerized to P-HPD. Finally there is a transfer of P-HPD's acetyl group to coenzyme A and the release of dihydroxyacetone phosphates.

PW124458

Pw124458 View Pathway
metabolic

qwer

actinobacillus succinogenes 130Z

PW056887

Pw056887 View Pathway
signaling

RA

Homo sapiens

PW056256

Pw056256 View Pathway
metabolic

ra

Homo sapiens